Phospholipid PL1 is a phospholipid-derived nanoparticle designed for immune modulation. It can deliver costimulatory receptor mRNA, such as CD137 or OX40, to T cells, which are crucial for immune responses. By doing so, PL1 induces the activation of various immune cells, including T cells and dendritic cells (DCs), thereby enhancing antitumor immunity. This ability makes PL1 a potential tool in immunotherapy, particularly in boosting the body's immune response against tumors. Reagent grade, for research purpose.
Usually ships within 24 hours.